Skip to content Skip to menu

In partnership with key stakeholders, Medicines Australia drives the creation and development of an environment for the continued sustainable growth of the innovative research based prescription medicines industry

About Us

Papers, Reports & Submissions

Publications

Agreements, Indemnity & Compensation Guidelines

Clinical Trials

Awards, Speeches & Media Releases

Media & Events

Member company lounge

Member's Area

New Facts Book shows more than 900 biologic medicines and vaccines in development

An informative source of key statistics and trends in the Australian and International medicines industry has today been published in the latest edition of the Medicines Australia Facts Book (4th Edition). The findings show that the global market for medicines and vaccines is set to double over the next decade, with much of the growth…

View article· Friday, 24 July 2015

Medicines Australia Provides Additional Submission to Senate Inquiry on Corporate Global Tax Issues

Australia’s innovative medicines industry body has provided a supplementary submission to the Senate Inquiry into Corporate Tax Avoidance addressing several issues raised at the public hearing in Sydney this month. Global tax arrangements such as transfer pricing are complex measures which are easily misunderstood. This can unfortunately lead to confusion within the community and erode…

View article· Thursday, 23 July 2015

Medical Research Future Fund will improve Australia’s competitiveness in world class innovation

Medicines Australia has tabled a submission urging the Parliament to pass legislation that will create the Medical Research Future Fund (MRFF). However, if the MRFF is to succeed in addressing the health needs of the future it needs close collaboration with Australia’s innovative medicines industry. The MRFF can be a positive step forward for Australia,…

View article· Monday, 13 July 2015

Stop the fearmongering: free trade and a globally competitive intellectual property system will benefit Australia

Medicines Australia remains concerned by the increasingly alarmist and misguided reporting by sections of the media on negotiations for the Trans Pacific Partnership (TPP) and its impacts on the prices for medicines in Australia. “The same fearmongering about price rises for medicines and the collapse of the Pharmaceutical Benefits Scheme (PBS) happened a decade ago…

View article· Thursday, 9 July 2015

Delivering commercial success from University research must involve the innovative research-based medicines industry

Medicines Australia welcomes the Federal Government review of University research funding and policy which aims to find more ways to turn the hard work of Australian scientists into commercial success. Medicines Australia CEO Tim James said, “Australia’s Universities have a great reputation for research and development around the world but they have often found it…

View article· Wednesday, 8 July 2015

Medicines Australia boosts Transparency measures in Code of Conduct

An awareness campaign has been launched by Medicines Australia to ensure healthcare professionals are aware of and understand the effects of new transparency enhancements contained in our updated Code of Conduct. From 1 October 2015, Medicines Australia 18th Edition of its Industry Code of Conduct will require payments to healthcare professionals to be disclosed online…

View article· Monday, 6 July 2015

Health Industry Forum outlines opportunities for investment and growth in Australia’s innovative medicines sector

Medicines Australia was pleased to attend the first Health Industry Forum, hosted by Industry Minister Ian Macfarlane MP, Health Minister Sussan Ley MP and Assistant Health Minister Fiona Nash MP at Parliament House today. The forum provided an opportunity for government and industry to work together to highlight opportunities for future investment and growth in…

View article· Thursday, 25 June 2015

Independent review of TGA provides sensible solutions to accelerate access to new Medicines

Medicines Australia welcomes the recommendations of an independent review into the Therapeutic Goods Administration (TGA) which, if adopted, will help to cut time delays and improve Australian’s access to new, innovative medicines. The Review examined the TGA’s regulatory framework and processes with a view to identifying areas of unnecessary red tape and opportunities to enhance…

View article· Thursday, 25 June 2015

Health Minister abandons Strategic Agreement with Medicines Australia – Medicines Industry stability and patient safety at risk

Medicines Australia is extremely disappointed with a last-minute decision by Health Minister Sussan Ley to abandon a Strategic Agreement, which casts a shadow over the future stability of the local medicines industry and also puts patient safety at risk. The purpose of the Agreement was to provide a level of stability and clarity for the…

View article· Tuesday, 23 June 2015

Grattan Institute misses the point, again

The Grattan Institute’s latest report seems to, again, miss the point. Enduring reforms to the Pharmaceutical Benefits Scheme (PBS) polices are achieving substantial savings for government and the Australian medicines industry is on the cusp of yet another; the biggest reform since 2007. “Measures currently before the Parliament will generate as much as $6.6 billion…

View article· Monday, 22 June 2015

Sign up for updates

Sign up for email updates to keep on top of Medicines Australia developments.


Social

CSL CFO giving speech on "the new economy: innovation and competitiveness" @ceda_news #Manufacturing #auspol #health http://t.co/Eyg4C6ou71

Check out this video 'World Head & Neck Cancer Day' http://t.co/jBX1e6tKHZ by IFHNOS. Raise awareness! #fightcancer http://t.co/waBaRAhPFo

Congrats Canberra runners for braving the cold yesterday in the Santa Speedo Shuffle run - raising over $100K for #cysticfibrosis @CFNSW

New Facts Book shows more than 900 biologic medicines and vaccines in development https://t.co/va53hQEziU

Medicines Australia Provides Additional Submission to Senate Inquiry on Corporate Global Tax Issues https://t.co/xzgKVEYfPG

#health story @Sue_Dunlevy @dailytelegraph - better cancer survival rates thru prevention measures & new treatments http://t.co/102YSigmIF

RT @timothycjames: At @PressClubAust listening to @amapresident Brian Owler. @MedicinesAus hosting colleagues. #health #pharma #auspol http…

RT @princetonagency: Up now: @MedicinesAus CEO Tim James presents, Pharma Onboard the Digital Innovation Journey. #DigiPharma

Break the silence and reduce the stigma of chronic pain #NationalPainWeek @ChronicPainAust

Interesting article on Aussie company CSL approaching its 100th year and its vital work in flu vaccination globally http://t.co/VbRUhkHLyv

Can an Aussie start-up be the next CSL, MSD or Pfizer? This healthcare investment expert says yes http://t.co/W5emWF2oIB @WhiteYt85

Read Prof. Tarnow Mordi on benefits of clinical trials to Australia @UniSydneyHealth Local trials down 20% since 2007 http://t.co/NNAe96d8zT

Hve you received the latest media release from Medicines Australia? Sign up for news updates & stay connected with us http://t.co/5BT9fl4TyU